Using calcium silicate to regulate the physicochemical and biological properties when using β-tricalcium phosphate as...

Current research in bone repair materials focuses on developing composites that combine osteoconductive and osteostimulative properties. β-Tricalcium phosphate (β-TCP) is known for its osteoconductive ability, but it lacks significant osteostimulative effects. Recent studies have explored the addition of bioactive components to improve performance. Calcium silicate (CS) has been proposed as a candidate due to its potential to enhance bioactivity and ion release. However, the precise role of CS in β-TCP composites remains unclear. This gap motivated researchers to investigate how varying CS content affects the physicochemical and biological properties of β-TCP. Prior research has shown that CS can promote apatite formation, but its impact on cell behavior has not been fully explored. The challenge lies in balancing degradation rates and bioactivity to optimize bone repair outcomes. No prior work had resolved how CS content influences both mechanical and biological performance. This uncertainty drove the need for a detailed study on β-TCP/CS composites.

The study aimed to evaluate the effects of varying calcium silicate (CS) content in β-tricalcium phosphate (β-TCP) composites on their physicochemical and biological properties. The primary goal was to assess how CS content influences apatite formation, mechanical strength, ion release, and degradation behavior. Researchers also sought to determine the impact of these composites on human dental pulp cell (hDPC) proliferation and differentiation. The motivation for this work stems from the need to develop biocomposites that support bone regeneration while maintaining structural integrity. The study focused on identifying an optimal CS-to-β-TCP ratio that enhances bioactivity without compromising mechanical properties. The researchers proposed that increasing CS content would improve osteostimulative effects. This approach is based on prior findings that CS can promote apatite formation and ion release. The specific problem addressed is the limited osteostimulative capacity of pure β-TCP.

To evaluate the properties of β-TCP/CS composites, researchers prepared a series of samples with varying CS content. They tested the composites for their ability to form bone-like apatite in simulated body fluid (SBF). The diametral tensile strength of each composite was measured to assess mechanical performance. Ion release and weight loss were also analyzed before and after immersion in SBF. In addition, the researchers examined the interaction between the composites and human dental pulp cells (hDPCs). Cell proliferation and differentiation were assessed using in vitro culture techniques. The study compared composites with CS content ranging from 0% to 100% in increments of 20%. The experimental design included both physicochemical and biological evaluations. The approach combined material science techniques with cell culture assays to provide a comprehensive assessment of the composites.

The results indicate that increasing CS content enhances the apatite deposition ability of β-TCP/CS composites. Composites with more than 60% CS content developed a dense bone-like apatite layer after immersion in simulated body fluid. Weight loss measurements showed a clear trend: composites with higher CS content experienced greater degradation. At the end of the immersion period, weight losses of 24%, 32%, 34%, 38%, 41%, and 45% were observed for composites containing 0%, 20%, 40%, 60%, 80%, and 100% β-TCP, respectively. The antibacterial activity of the composites also improved with increasing CS content. In vitro cell experiments revealed that CS-rich composites promoted human dental pulp cell (hDPC) proliferation and differentiation. When CS content was less than 60%, the release of Si from the composites stimulated cell growth and osteogenesis protein production. The degradation of β-TCP and the osteostimulative properties of CS suggest that these composites could be suitable for bone repair applications. The observed trends in apatite formation and cell behavior support the hypothesis that CS enhances the bioactivity of β-TCP.

The authors propose that β-TCP/CS composites with higher CS content exhibit improved bioactivity and osteostimulative properties. The study suggests that increasing CS content enhances apatite formation and promotes human dental pulp cell proliferation. The observed weight loss trends indicate that composites with more than 60% CS degrade more rapidly. The antibacterial activity of the composites also increases with CS content. The in vitro results suggest that CS-rich composites stimulate osteogenesis through Si release. The degradation of β-TCP and the osteostimulative effects of CS support the potential of these composites for bone repair. The findings suggest that β-TCP/CS composites may serve as effective materials for bone regeneration. The authors conclude that these composites could be suitable for clinical applications in bone repair.